S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
S&P 500   5,252.29 (+0.07%)
DOW   39,739.39 (-0.05%)
QQQ   444.74 (-0.02%)
AAPL   170.80 (-1.45%)
MSFT   421.11 (-0.08%)
META   489.33 (-0.92%)
GOOGL   150.54 (-0.22%)
AMZN   180.79 (+0.53%)
TSLA   177.68 (-1.20%)
NVDA   906.12 (+0.40%)
NIO   4.63 (-0.86%)
AMD   181.56 (+1.10%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.23 (+1.30%)
MU   118.36 (-0.65%)
CGC   9.29 (-2.72%)
GE   175.04 (-2.82%)
DIS   122.08 (+0.91%)
AMC   3.80 (-12.44%)
PFE   27.89 (+0.40%)
PYPL   67.14 (+0.86%)
XOM   115.66 (+0.60%)
NYSE:PEAK

Healthpeak Properties (PEAK) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
$16.18
$20.84
52-Week Range
N/A
Volume
9.98 million shs
Average Volume
7.81 million shs
Market Capitalization
$9.36 billion
P/E Ratio
30.54
Dividend Yield
7.02%
Price Target
$23.05

Healthpeak Properties MarketRank™ Stock Analysis

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
∞ Upside
$23.05 Price Target
Short Interest
Healthy
1.63% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-1.84
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Acquiring Shares
$300,780 Bought Last Quarter
Proj. Earnings Growth
6.78%
From $1.77 to $1.89 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.86 out of 5 stars

Finance Sector

33rd out of 859 stocks

Real Estate Investment Trusts Industry

6th out of 180 stocks

PEAK stock logo

About Healthpeak Properties Stock (NYSE:PEAK)

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

PEAK Stock News Headlines

Healthpeak Properties Inc DOC
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
PEAK Oct 2024 17.500 call
Invest Like Bill Gates with These REITs
American Homes 4 Rent Set to Join S&P MidCap 400
Healthpeak Properties Inc.
OHI Apr 2024 28.000 put
2024 Space Awards: Top real estate deals and leases
7 High-Yield Dividend Leaders to Unlock Superior Returns
See More Headlines
Receive PEAK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Healthpeak Properties and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Ex-Dividend for 2/26 Dividend
2/13/2024
Dividend Payable
2/26/2024
Today
3/28/2024
Next Earnings (Estimated)
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real estate investment trusts
Sub-Industry
N/A
Employees
193
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.05
High Stock Price Target
$32.00
Low Stock Price Target
$17.50
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
10 Analysts

Profitability

Net Income
$306.01 million
Pretax Margin
14.44%

Debt

Sales & Book Value

Annual Sales
$2.18 billion
Book Value
$12.57 per share

Miscellaneous

Free Float
546,133,000
Market Cap
$9.36 billion
Optionable
Optionable
Beta
1.01
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives


PEAK Stock Analysis - Frequently Asked Questions

Should I buy or sell Healthpeak Properties stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthpeak Properties in the last twelve months. There are currently 1 sell rating, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" PEAK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PEAK, but not buy additional shares or sell existing shares.
View PEAK analyst ratings
or view top-rated stocks.

What is Healthpeak Properties' stock price target for 2024?

10 brokerages have issued 12-month price objectives for Healthpeak Properties' stock. Their PEAK share price targets range from $17.50 to $32.00. On average, they expect the company's stock price to reach $23.05 in the next year.
View analysts price targets for PEAK
or view top-rated stocks among Wall Street analysts.

When is Healthpeak Properties' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our PEAK earnings forecast
.

How were Healthpeak Properties' earnings last quarter?

Healthpeak Properties, Inc. (NYSE:PEAK) announced its quarterly earnings results on Thursday, February, 8th. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.45 by $0.32. The company had revenue of $553.65 million for the quarter, compared to analysts' expectations of $553.77 million. Healthpeak Properties had a trailing twelve-month return on equity of 4.34% and a net margin of 13.97%. The firm's quarterly revenue was up 5.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.44 earnings per share.

How often does Healthpeak Properties pay dividends? What is the dividend yield for Healthpeak Properties?

Healthpeak Properties announced a quarterly dividend on Wednesday, January 31st. Investors of record on Wednesday, February 14th will be paid a dividend of $0.30 per share on Monday, February 26th. This represents a $1.20 annualized dividend and a dividend yield of ∞. The ex-dividend date of this dividend is Tuesday, February 13th.
Read our dividend analysis for PEAK
.

Is Healthpeak Properties a good dividend stock?

Healthpeak Properties (NYSE:PEAK) pays an annual dividend of $1.20 per share and currently has a dividend yield of 7.02%. PEAK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 214.29%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, PEAK will have a dividend payout ratio of 63.49% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PEAK.

What guidance has Healthpeak Properties issued on next quarter's earnings?

Healthpeak Properties updated its FY24 earnings guidance on Friday, March, 1st. The company provided EPS guidance of $1.73-1.79 for the period, compared to the consensus EPS estimate of $1.78.

What is Thomas M. Herzog's approval rating as Healthpeak Properties' CEO?

10 employees have rated Healthpeak Properties Chief Executive Officer Thomas M. Herzog on Glassdoor.com. Thomas M. Herzog has an approval rating of 100% among the company's employees. This puts Thomas M. Herzog in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Healthpeak Properties' major shareholders?

Healthpeak Properties' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (16.04%), Vanguard Group Inc. (16.04%), Centersquare Investment Management LLC (2.19%), Legal & General Group Plc (1.86%), Norges Bank (1.52%) and Dimensional Fund Advisors LP (1.48%). Insiders that own company stock include Christine Garvey, Sara Grootwassink Lewis, Scott M Brinker and Thomas Klaritch.
View institutional ownership trends
.

How do I buy shares of Healthpeak Properties?

Shares of PEAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:PEAK) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners